Roche Holding AG ( RHHBF) - Key Metrics
RHHBF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q2 | ? | ? | ? | ? |
| 2024Q4 | $38.53 | $2.54 | $14.69 | $12.42 |
| 2024Q2 | $38.49 | $7.83 | $9.90 | $7.75 |
RHHBF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q2 | ? | ? |
| 2024Q4 | ? | 25.16 |
| 2024Q2 | 122.24% | 7.98 |
RHHBF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 2.03% | ? |
| 2025Q4 | 3.26% | ? |
| 2025Q2 | 1.28% | ? |
| 2024Q4 | 4.08% | ? |
| 2024Q2 | 2.95% | 3.83% |
RHHBF
Price: $479.42
Dividend Yield: 2.90%
Forward Dividend Yield: 5.18%
Payout Ratio: 70.22%
Dividend Per Share: 24.82 USD
Earnings Per Share: 19.81 USD
P/E Ratio: 23.47
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: Switzerland
Market Capitalization: 340.7 billion
Average Dividend Frequency: 2
Years Paying Dividends: 25
DGR3: 30.00%
DGR5: 23.68%
DGR10: 12.92%
DGR20: 12.90%